GSA CAPITAL PARTNERS LLP - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 85 filers reported holding SEELOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$57
-19.7%
48,018
-54.3%
0.01%
-33.3%
Q4 2022$71
-99.9%
105,050
-23.5%
0.01%
-52.6%
Q3 2022$141,000
+642.1%
137,266
+398.4%
0.02%
+533.3%
Q2 2022$19,000
-90.3%
27,541
-66.0%
0.00%
-85.0%
Q3 2021$195,000
+387.5%
80,998
+216.9%
0.02%
+185.7%
Q4 2020$40,000
+53.8%
25,557
-6.9%
0.01%
+75.0%
Q3 2020$26,00027,4370.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Uniplan Investment Counsel, Inc. 2,033,020$1,904,0000.13%
1492 Capital Management LLC 150,000$141,0000.11%
Spark Investment Management LLC 13,100$12,0000.02%
ARDSLEY ADVISORY PARTNERS LP 80,000$75,0000.01%
GSA CAPITAL PARTNERS LLP 27,437$26,0000.00%
WealthPLAN Partners, LLC 20,000$18,0000.00%
CIBC WORLD MARKET INC. 500,000$468,0000.00%
CAPITAL COUNSEL LLC/NY 10,000$9,0000.00%
J.W. COLE ADVISORS, INC. 10,000$9,0000.00%
Renaissance Technologies 591,086$554,0000.00%
View complete list of SEELOS THERAPEUTICS INC shareholders